Previous close | 396.68 |
Open | 398.30 |
Bid | 395.52 x 1000 |
Ask | 397.19 x 800 |
Day's range | 393.92 - 407.09 |
52-week range | 318.50 - 695.18 |
Volume | |
Avg. volume | 612,912 |
Market cap | 33.004B |
Beta (5Y monthly) | 1.14 |
PE ratio (TTM) | 51.28 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Designed to thrive in challenging economic conditions, these companies are great buys during a downturn.
Every investor in IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) should be aware of the most powerful shareholder groups...
Participating in the call this morning are Jay Mazelsky, president and chief executive officer; Brian McKeon, chief financial officer; and John Ravis, vice president, investor relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements.